Fragment 176-191
Weight Loss & Metabolism Support
$18.00
Out of stock
Research suggests Fragment 176–191 (AOD-9604), a modified HGH C-terminal peptide, is investigated for selective lipolytic activity without impacting glucose or growth pathways.
For Research Use Only
These compounds are strictly intended for use in laboratory research settings and are not formulated, tested, or approved for any medical, therapeutic, or clinical application. They have not been evaluated or authorized by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, mitigation, cure, or prevention of any disease or health condition. By proceeding with a purchase, you affirm and acknowledge that these materials will be used exclusively for in vitro or other non-clinical scientific research purposes—and under no circumstances will they be administered to humans or animals.